Additionally, BCL9 did not regulate the expression of integrin αV, the heterodimer binding partner of integrin β3, in DCIS.COM or SUM225 cells (Supplementary Fig. 6e, f). Here, BCL9 is linked to ductal breast carcinoma in situ.